NS 1209
Code | Size | Price |
---|
TAR-T4009-5mg | 5mg | £344.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4009-10mg | 10mg | £457.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4009-25mg | 25mg | £766.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
NS1209 is a AMPA receptor antagonist.
CAS:
205645-02-9
Formula:
C24H27N4NaO7S
Molecular Weight:
538.55
Pathway:
Neuroscience
Purity:
0.98
SMILES:
[Na+].CN(C)S(=O)(=O)c1ccc(cc1)-c1cc2C(=NOC(CCO)C([O-])=O)C(=O)Nc2c2CN(C)CCc12
Target:
GluR
References
Gormsen L., et al. The efficacy of the AMPA receptor antagonist NS1209 and lidocaine in nerve injury pain: a randomized, double-blind, placebo-controlled, three-way crossover study. Anesth Analg. 2009 Apr;108(4):1311-9.
Langer M., et al. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Neuropharmacology. 2011 Oct-Nov;61(5-6):1033-47.